Home › Funds › Rock Springs Capital Management LP › MIRM

Rock Springs Capital Management LP position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

Rock Springs Capital Management LP reported holding 779,790 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$66.7M, representing 3.61% of its reported portfolio and ranking #5 among its reported holdings. Rock Springs Capital Management LP has disclosed MIRM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)779.79K sh
Reported value held$66.66M
Portfolio Weight3.61%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's MIRM position evolved

Rock Springs Capital Management LP first disclosed a stake in MIRM in Q3 2023 at 1,820,733 shares (US$57.5M). The position peaked in Q2 2026 at 798,145 shares, worth US$93.4M. Across 13 filings, Rock Springs Capital Management LP increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 779,790 shares valued at US$66.7M — a reduction of -18,355 shares quarter over quarter.. Notable position changes include a 35% trim in Q1 2025 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.82M $57.54M New
Q4 2023 1.85M $54.66M Add
Q1 2024 1.86M $46.64M Hold
Q2 2024 1.77M $60.59M Reduce
Q3 2024 1.58M $61.64M Reduce
Q4 2024 1.47M $60.85M Reduce
Q1 2025 951.76K $42.88M Reduce
Q2 2025 818.21K $41.64M Reduce
Q3 2025 761.13K $55.80M Reduce
Q4 2025 762.29K $60.21M Hold
Q1 2026 811.29K $74.95M Add
Q2 2026 798.14K $93.44M Reduce
Q3 2026 779.79K $66.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 45 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), TANG CAPITAL MANAGEMENT LLC (US$144.7M), Novo Holdings A/S (US$131.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has Rock Springs Capital Management LP held MIRM?

Rock Springs Capital Management LP has disclosed MIRM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in MIRM?

As of Q3 2026, Rock Springs Capital Management LP holds 779.79K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $66.66M, representing 3.61% of its reported portfolio and ranking #5.

Has Rock Springs Capital Management LP been buying or selling MIRM?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP reduced its position in MIRM. The position peaked in Q2 2026 at 798.14K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., TANG CAPITAL MANAGEMENT LLC, Novo Holdings A/S, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.